compounded tirzepatide ending NYC: Online Program for Weight Loss COMPOUNDED TIRZEPATIDE

it is provided with the understanding that Poosh, LLC (Poosh) is not engaged in the provision or rendering of medical advice or services

doi: 10.1152/ajpheart.1994.267.5.H1862

10.1016/j.vph.2018.02.010 147 VukojevicJ.VrdoljakB.MalekinusicD.SiroglavicM.MilavicM.KolencD.et al (2020)

A Phase 3b, Randomized, Multicenter, Controlled Study of Mirikizumab and Placebo or Mirikizumab Concomitantly Administered With Tirzepatide in Adult Participants With Moderately to Severely Active Crohns Disease and Obesity or Overweight [Internet]

For more details relating to risks of investing in the Funds, please refer to the "Risk Factors" section of the Fund's prospectus